ERASCA, INC.

(ERAS)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 05/26 01:14:27 pm
5.74 USD   +4.55%
05/25Erasca Strengthens Clinical and Commercial Leadership with Three Key Appointments
AQ
05/25Erasca, Inc. Announces Key Appointments
CI
05/12Erasca Narrows Q1 Loss, Misses Street Estimates
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Other Biotechnology & Medical Research
10:41aZOOM VIDEO COMMUNICATIONS, INC. : An attempt to reconnect
07:07aINSIDER SELL : Moderna
MT
05/25SECTOR UPDATE : Health Care Stocks End Near Unchanged
MT
05/25SECTOR UPDATE : Health Care Stocks Falling This Afternoon
MT
05/25SECTOR UPDATE : Health Care
MT
05/25French health body backs new COVID vaccine booster campaign for this autumn
RE
05/24Lonza Ties Up With Israel Biotech Fund On Biologics, Small Molecule Development, Manufa..
MT
05/24Moderna's CEO Stephane Bancel to Exercise Shares, Intends to Donate Proceeds to Charity
MT
05/24Rubius Therapeutics Names Noubar Afeyan Chairman; Shares Rise Pre-Bell
MT
05/24TRANSCRIPT : Moderna, Inc. Presents at UBS Global Healthcare Conference, May-24-2022 09:15..
CI
05/24Moderna testing potential monkeypox vaccines
RE
05/24Moderna CEO to Exercise 2013 Option, Donate Funds to Charity
DJ
05/24ANALYST RECOMMENDATIONS : Chubb, Glencore, Metlife, Moonpig, Salesforce...
05/24Guggenheim Starts IQVIA Holdings at Buy With $244 Price Target
MT
05/23Switzerland's Lonza to Scale Up Inhalation Capabilities at US Site
MT
05/23Seagen Sees Positive Topline Data From Study of Tukysa With Trastuzumab in HER2-Positiv..
MT
05/23What you need to know about the coronavirus right now
RE
05/23Seagen Inc. Announces Positive Topline Results of Pivotal Phase 2 Clinical Trial of TUK..
CI
05/23INSIDER SELL : Moderna
MT
05/19EU health regulator backs using AstraZeneca COVID shot as booster
RE
05/18Moderna Seeks Swissmedic Nod For COVID-19 Shot In Children Aged Six Months To Five year..
MT
05/18As COVID cases rise, U.S. health officials mull widening additional booster eligibility
RE
05/18Lonza Opens New Facility for Kodiak Sciences' Retinal Diseases Drug
MT
05/18Moderna, International AIDS Vaccine Initiative to Start Volunteer Screening for Phase 1..
MT
05/18Piper Sandler Adjusts Moderna's Price Target to $214 From $348, Reiterates Overweight R..
MT
05/18From storage to transport, hurdles to getting COVID vaccine to N.Koreans
RE
05/17TRANSCRIPT : Moderna, Inc. - Special Call
CI
05/17FDA Expands Authorization of Pfizer Covid Booster to Kids 5 to 11
DJ
05/16US Stocks Begin Week Mostly Lower Amid Empire State Manufacturing Weakness
MT
05/16US Stocks Begin Week Mostly Lower as First Manufacturing Data for May Turns Negative
MT
05/16Top Midday Gainers
MT
05/16INSIDER SELL : Seagen
MT
05/16Seagen's President, CEO Clay Siegall Resigns Amid Investigation
MT
05/16Seagen Announces Resignation of Clay Siegall as CEO
CI
05/13SECTOR UPDATE : Health Care Stocks Gain Premarket Friday
MT
05/13Swiss Medical Regulator Approves Moderna's Covid-19 Vaccine for 6-11-Year-Olds
MT
05/13Swissmedic OKs Moderna's COVID-19 Jab For Children Aged Six To 11 Years
MT
05/13N.Korea gets offers of aid to fight COVID as it lacks vaccines
RE
05/13Switzerland authorizes Moderna's COVID vaccine for 6-11 year olds
RE
05/11Moderna completes FDA submission for use of COVID shot in adolescents, kids
RE
05/11Moderna, Inc. Fires Jorge Gomez as CFO
CI
05/11Pfizer's $11.6 billion Biohaven buy could spark more biotech deals
RE
05/11Moderna Ousts New Finance Chief Amid Probe at Dentsply
DJ
05/11Moderna Says Recently Named CFO Jorge Gomez Departs; David Meline Continues as CFO
MT
05/11Moderna CFO, Jorge Gomez, Resigns Effective Immediately
MT
05/11Moderna CFO exits a day after taking charge as former employer launches probe
RE
05/11Moderna's new CFO Jorge Gomez steps down
RE
05/10What you need to know about the coronavirus right now
RE
05/10Novavax shares slide 20% on COVID vaccine demand uncertainty
RE
05/09Lonza, ALSA Ventures Partner To Support Development Of Small Molecule Drug Candidates
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ERASCA, INC.